NDC 72205-034-46 - Lacosamide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72205-034
- Requested NDC
- 72205-034-46
- Package NDCs from labels
- 72205-034-75, 72205-034-74, 72205-034-44, 72205-034-50, 72205-034-45, 72205-034-91, 72205-034-46, 72205-034-93, 72205-034-47, 72205-034-94
- Manufacturer
- Novadoz Pharmaceuticals LLC | MSN Pharmaceuticals Inc.
- Effective date
- 2026-08-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lacosamide - Novadoz Pharmaceuticals LLC | MSN Pharmaceuticals Inc. | Novadoz Pharmaceuticals LLC | MSN Pharmaceuticals Inc. | 2026-08-12 | Human Prescription Drug Label |
| Lacosamide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72205-034-44 | Lacosamide | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 2 | |
| 72205-034-45 | Lacosamide | 10 mL in 1 CUP, UNIT-DOSE | SOLUTION | 10 | 2 | |
| 72205-034-46 | Lacosamide | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 2 | |
| 72205-034-47 | Lacosamide | 20 mL in 1 CUP, UNIT-DOSE | SOLUTION | 20 | 2 | |
| 72205-034-50 | Lacosamide | 1 in 1 BOX | SOLUTION | 1 | 2 | |
| 72205-034-50 | Lacosamide | 10 in 1 TRAY | SOLUTION | 10 | 2 | |
| 72205-034-74 | Lacosamide | 200 mL in 1 BOTTLE, PLASTIC | SOLUTION | 200 | 2 | |
| 72205-034-75 | Lacosamide | 465 mL in 1 BOTTLE, PLASTIC | SOLUTION | 465 | 2 | |
| 72205-034-91 | Lacosamide | 1 in 1 BOX | SOLUTION | 1 | 2 | |
| 72205-034-91 | Lacosamide | 10 in 1 TRAY | SOLUTION | 10 | 2 | |
| 72205-034-93 | Lacosamide | 1 in 1 BOX | SOLUTION | 1 | 2 | |
| 72205-034-93 | Lacosamide | 10 in 1 TRAY | SOLUTION | 10 | 2 | |
| 72205-034-94 | Lacosamide | 10 in 1 TRAY | SOLUTION | 10 | 2 | |
| 72205-034-94 | Lacosamide | 1 in 1 BOX | SOLUTION | 1 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72205-034-74 | ML - Milliliter | 72205-034 | 6494c70d-1486-4450-81e9-54481a0c8e9e | 1 | 2024-07-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mitochondria Pro | ARALIA QUINQUEFOLIA, ARNICA MONTANA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, ASCORBICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CALCAREA CARBONICA, CITRICUM ACIDUM, CUPRUM METALLICUM, CYSTEINUM, FERRUM METALLICUM, IODIUM, LEVOTHYROXINUM, MAGNESIUM GLUCONICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM ACETICUM, NADIDUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SELENIUM METALLICUM, SULPHUR, THIAMINUM HYDROCHLORICUM, UBIDECARENONUM, ZINCUM METALLICUM, | Energique, Inc. | 2f365207-b730-428d-9465-8853e86e79ff | 2026-02-18 | Warnings | XF417D3PSL |
| RHODODIUM | ACTEA RACEMOSA, APIS MELL, CALC CARB, GRAPHITES, IODIUM, NATRUM MUR, PULSATILLA, RHODODENDRON | BM Private Limited | 3b3bcba2-6f9e-cd94-e063-6394a90a7701 | 2026-02-15 | Warnings | 451W47IQ8X |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Lacosamide Oral Solution | LACOSAMIDE ORAL | Florida Pharmaceutical Products, LLC | ba4e2e28-7dc3-47b3-9c2c-34e0b1f39fb8 | 2026-02-12 | Warnings, Adverse reactions | 993856 563KS2PQY5 |
| Walgreens ULTRA FINE MOISTURIZING SALINE MIST | NASAL MIST | WALGREEN COMPANY | 48fef521-1b1d-d0d5-e063-6394a90ac7b1 | 2026-02-10 | Warnings | 451W47IQ8X |
| Walgreens SALINE MIST | NASAL MIST | WALGREEN COMPANY | 44815675-cc1d-a582-e063-6394a90ae8f6 | 2026-02-10 | Warnings | 451W47IQ8X |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Droptics Performance Eye Drops | NAPHAZOLINE HYDROCHLORIDE, PROPYLENE GLYCOL | Droptics LLC | 20fd6822-a7fd-4593-92bb-0a07260893e2 | 2026-02-09 | Warnings | 6DC9Q167V3 |
| 0.9 percentsaline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 487cb4fc-2e0b-020f-e063-6294a90a4526 | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e76aca-ca2b-3b95-e063-6394a90a875e | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9%saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e7b329-e4e5-6991-e063-6294a90ac817 | 2026-02-03 | Warnings | 451W47IQ8X |
| Adrenal Support | ADRENALINUM, BERBERIS VULGARIS, ARGENTUM NITRICUM, NATRUM MURIATICUM, VANADIUM METALLICUM, OLEUM MORRHUAE, PETROLEUM | NaturalCare | cee52757-a86e-4251-b65f-954ac85f4e7e | 2026-01-30 | Warnings | 451W47IQ8X |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Vital Female Sexual Energy | AGNUS CASTUS, ARNICA MONTANA, AVENA SATIVA, CAULOPHYLLUM THALICTROIDES, CINCHONA OFFICINALIS, DAMIANA, HYPOPHYSIS SUIS, L-ARGININE, NATRUM MURIATICUM, OOPHORINUM SUIS, PHOSPHORICUM ACIDUM, SABAL SERRULATA, SEPIA, THUJA OCCIDENTALIS | Liddell Laboratories, Inc. | 7b15d6fa-eb04-41d2-8a01-6e7408ccf4d3 | 2026-01-30 | Warnings | 451W47IQ8X |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 451W47IQ8X |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.